Clinical Trial

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

Study acronym: GEM-S
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This phase III trial compares the effect of geriatric evaluation and management with survivorship health education (GEM-S) to usual care on patient-reported physical function in older survivors of cancer. Survivorship care for older adults of cancer usually consists of getting advice from their doctor. This advice may include how to do their daily activities, so they are less tired or how to manage multiple diseases, or long-term side effects from treatment. GEM-S may help improve the physical ability to perform activities of daily living, mental well-being, and memory in older survivors of cancer after chemotherapy. This study may help doctors learn if including GEM-S in their practices improves physical, mental and memory functions in their patients. The study may also help to understand how such care affects cancer patients and their caregivers' quality of life.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2021-08-09; most recent amendment 2026-01-10.
Status change: Not Yet Recruiting → Recruiting 2023-02-08
Trial Details
NCT Number NCT05006482
Lead Sponsor University of Rochester
Collaborators: National Cancer Institute (NCI)
Conditions Lymphoma, Malignant Solid Neoplasm
Enrollment 668 participants
Start Date 2023-03-21
Primary Completion 2027-05-17 (estimated)
Study Completion 2027-09-17 (estimated)
Updated on ClinicalTrials.gov 2026-01-13